• Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Brokerages

    المصدر: Buzz FX / 19 مارس 2025 02:41:16   America/New_York


    Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) Receives Average Recommendation of "Moderate Buy" from Brokerages Written by MarketBeat March 19, 2025 Share Link copied to clipboard. Remove Ads Crinetics Pharmaceuticals, Inc.
    Read more...
شارك على،